Your browser doesn't support javascript.
loading
The new paradigm of systemic therapies for metastatic melanoma.
Volpe, Virginia O; Klufas, Daniel M; Hegde, Upendra; Grant-Kels, Jane M.
Afiliación
  • Volpe VO; Department of Internal Medicine, Division of Oncology's Neag Cancer Center, University of Connecticut Health Center, Farmington, Connecticut.
  • Klufas DM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Hegde U; Department of Internal Medicine, Division of Oncology's Neag Cancer Center, University of Connecticut Health Center, Farmington, Connecticut.
  • Grant-Kels JM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut. Electronic address: grant@uchc.edu.
J Am Acad Dermatol ; 77(2): 356-368, 2017 Aug.
Article en En | MEDLINE | ID: mdl-28711086
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Inhibidores de Proteínas Quinasas / Factores Inmunológicos / Melanoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Inhibidores de Proteínas Quinasas / Factores Inmunológicos / Melanoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2017 Tipo del documento: Article